30 Years of Evidence

Image-guided LINAC Radiosurgery in Hypothalamic Hamartomas

Romanelli P, Tuniz F, Fabbro S, Beltramo G, Conti A | Front Neurol | 2022

Safety and Efficacy of Hypofractionated Stereotactic Radiosurgery in Facial Nerve Schwannoma

Fatima N, La Dine AK, Barnard ZR, Ko K, Peng K, Slattery WH, Lekovic GP | Otol Neurotol | 2023

Efficiency and Safety of CyberKnife Robotic Radiosurgery in the Multimodal Management of Patients with Acromegaly

Romero-Gameros CA, González-Virla B, Vargas-Ortega G, Sosa-Eroza E, Rendón-Macías ME, Balcázar-Hernández LJ, Mercado M, Velasco-Cortes N, Rodea-Ávila CA, Flores-Robles L, Lorenzana-Hernández JA, Vázquez-Rojas J, López-Palma M | Cancers (Basel) | 2023

Stereotactic Body Radiotherapy Boost with the CyberKnife for Locally Advanced Cervical Cancer: Dosimetric Analysis and Potential Clinical Benefits

Gao J, Xu B, Lin Y, Xu Z, Huang M, Li X, Wu X, Chen Y. | Cancers (Basel) | 2022

Ablative vs. Non-Ablative Radiotherapy in Palliating Locally Advanced Pancreatic Cancer: A Single Institution Experience and a Systematic Review of the Literature

Kamel R, Dennis K, Doody J, Pantarotto J. | Cancers (Basel) | 2023

First UK Patient Cohort Treated with Stereotactic Ablative Radiotherapy for Primary Kidney Cancer

Zarkar A, Henderson D, Carver A, Heyes G, Harrop V, Tutill S, Kilkenny J, Marshall A, Elbeltagi N, Howard H | BJUI Compass | 2023

Potential Benefit of Dose-Escalated Stereotactic Body Radiation Therapy using CyberKnife for Early-Stage Primary Lung Cancer

Watanabe S, Yamazaki H, Kimoto T, Shiomi H, Yamada K, Suzuki G | Asia Pac J Clin Oncol | 2023

Stereotactic Ablative Body Radiotherapy with w Central High Dose using CyberKnife for Metastatic Lung Tumors

Hayashi K, Suzuki O, Shiomi H, Ono H, Setoguchi A, Nakai M, Nakanishi E, Tatekawa S, Ose N, Hirata T, Tamari K, Seo Y, Funaki S, Isohashi F, Shimizu S, Shintani Y, Ogawa K | BMC Cancer | 2023

30 Years of Evidence